Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer'S Disease in App/Ps1 Transgenic Mice

Shuang-Qing Chen,Pei-Jun Wang,Gao-Jun Ten,Wei Zhan,Ming-Hua Li,Feng-Chao Zang
DOI: https://doi.org/10.1159/000261646
2009-01-01
Dementia and Geriatric Cognitive Disorders
Abstract:BACKGROUND/AIMS:To explore the potential value of myo-inositol (mIns), which is regarded as a biomarker for early diagnosis of Alzheimer's disease, in APP/PS1 transgenic (tg) mice detected by (1)H-MRS.METHODS:(1)H-MRS was performed in 30 APP/PS1 tg mice and 20 wild-type (wt) littermates at 3, 5 and 8 months of age. Areas under the peak of N-acetylaspartate (NAA), mIns and creatine (Cr) in the frontal cortex and hippocampus were measured, and the NAA/Cr and mIns/Cr ratios were analyzed quantitatively.RESULTS:Compared with the wt mice, the mIns/Cr ratio of the 3-month-old tg mice was significantly higher (p < 0.05), and pathology showed activation and proliferation of astrocytes in the frontal cortex and hippocampus. The concentration of NAA was significantly lower at 8 and 8 months of age (p < 0.05). According to the threshold of mIns/Cr that was adopted to separate the tg from the wt mice, the rate of correct predictions was 82, 94 and 95%, respectively, for 3, 5 and 8 months.CONCLUSION:Of the early AD metabolites as detected by (1)H-MRS, mIns is the most valuable marker for assessment of AD. Quantitative analysis of mIns may provide important clues for early diagnosis of AD.
What problem does this paper attempt to address?